Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
about
Antibiotic treatment for Clostridium difficile -associated diarrhea in adultsTeicoplanin versus vancomycin for proven or suspected infectionTeicoplanin versus vancomycin for proven or suspected infectionAntibiotic treatment for Clostridium difficile-associated diarrhea in adultsAntibiotic treatment for Clostridium difficile-associated diarrhea in adultsBench-to-bedside review: Clostridium difficile colitisComparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infectionsEfficacy and Safety of Metronidazole Monotherapy versus Vancomycin Monotherapy or Combination Therapy in Patients with Clostridium difficile Infection: A Systematic Review and Meta-AnalysisClostridium difficile Infection in Children: Current State and Unanswered QuestionsRecurrent Clostridium difficile infections: the importance of the intestinal microbiotaTrends in Clostridium difficile Disease: Epidemiology and InterventionAntibiotic treatment for Clostridium difficile-associated diarrhoea in adults.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.A Review of Experimental and Off-Label Therapies for Clostridium difficile InfectionClostridium difficile infection: New insights into therapeutic options.Antibiotic Regimen after a Total Abdominal Colectomy with Ileostomy for Fulminant Clostridium difficile Colitis: A Multi-Institutional Study.Management and Prevention of Clostridium difficile-Associated Diarrhea.Clostridium difficile infection: guideline-based diagnosis and treatmentFidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.Antimicrobial susceptibilities and serogroups of clinical strains of Clostridium difficile isolated in France in 1991 and 1997.Clinical review of the management of fulminant clostridium difficile infection.Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.Drug-induced diarrhoea.The potential value of Clostridium difficile vaccine: an economic computer simulation model.Clostridium difficile infection in the inflammatory bowel disease patient.Clostridium difficile colitis: a review.Clostridium difficile infection in patients with neutropenia.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.New antimicrobial agents for patients with Clostridium difficile infections.Clostridium difficile: progress and challenges.A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy.Treatment of Clostridium difficile-associated diarrhea.Clostridium difficile in long-term-care facilities for the elderly.Efficacy of fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infectionsClostridium difficile Infection and Inflammatory Bowel Disease: A Review.Clostridium difficile infection: current, forgotten and emerging treatment options.Management of infectious diarrhoeaClostridium difficile-associated diarrhea in adultsClostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.
P2860
Q24234378-69262093-F227-40FD-B864-0C0BE6429623Q24234764-94D4F358-9035-4110-921E-D412D9B13919Q24243707-4FFC5FFA-17E5-44BA-B6A4-E4E3C5EEB357Q24244302-DCA4738C-25DC-4B53-A8D7-C93E66A32043Q24244843-B114C2FB-43C5-48C3-9CD8-A0637C9D9978Q24644191-B1280827-07B8-4706-B52D-C46F713E8267Q26752760-B96BB5E4-0A9E-4130-AA63-2C52FCF67293Q26786662-EF3F4911-5057-47D5-B6DB-E3359B34B4A6Q27016320-A7A08583-9323-4EDB-9B79-F914E0B9EA4BQ27023219-3A452C94-FE4B-4743-82CB-285E1B6B1F0EQ28655729-68D7847D-0A6F-477E-84CF-F0AA31F3F592Q30235446-4C342661-0AD7-4CA5-8C96-CA1B9F0542A6Q30238945-A0BDF2D9-C907-428D-9E92-5E335F7295C7Q30240264-6324E4ED-39A9-465A-93B7-01B89DB55578Q30252154-B32E494B-05AC-4D62-AD7A-50AB3CE03D09Q30279196-06B75E20-4E69-4C1F-8205-9041E25C7558Q30307170-F13D04B6-7D3F-4395-93C0-CE6BE6D19DD1Q30316981-A1C2F7D0-D5B9-46F3-A20F-ADDB6CE9E127Q30425705-F8FEEB21-2640-4278-89FB-1A60096E13B0Q30804635-863D95D9-E813-444A-97D4-CB8D5724666CQ33375824-DFEA7833-2F2A-4D9C-A58F-3B428E6849BEQ33782277-F8A1DA68-C7D4-4183-AD6D-933FDF1540E4Q33824847-73D17148-21A4-4160-B306-D5E7A364DCFDQ34012314-AF80752C-2A65-4437-9DF3-477D9EA671B2Q34234668-20F96ACA-E4AA-4BC8-9950-AD4360FF8298Q34260389-90EC7BCC-CADD-41CF-A896-F12A633A6180Q34340965-7CC2AD38-3BD9-4413-93C4-7FBEE18770A3Q34557101-836AE993-E949-40C6-BBE7-4D28814B409CQ34602195-50A66658-00E7-4CBB-BCCE-56840B147718Q34625939-887C4FFC-4094-4584-8265-FB08D13FC776Q34643123-BA4EFA2B-A10F-4ABE-9810-FF5FB77052F6Q34767730-677A3C5D-DED4-4BDC-93AC-D6D46DD2EE27Q34979678-8413FD4D-5749-4C02-85FC-4C27237A3A05Q35009239-ED12B5D8-0300-42C4-92A8-2C0C5928BECFQ35164536-F61D376B-5180-488B-85EB-66140C72E77DQ35208564-96E3D104-9C61-4F59-B6D1-D84BA93A3E42Q35372397-15D33CC6-7D8C-4D75-8554-B7B1D558C2C0Q35598312-B3727137-873E-4A7C-9706-CF164F23E6EFQ35828291-B40ED1F3-79B2-411D-9A83-8C4946373EAEQ35874779-945BDBD8-0505-40B6-89F6-1BB90B82FEF9
P2860
Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@ast
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@en
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@nl
type
label
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@ast
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@en
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@nl
prefLabel
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@ast
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@en
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@nl
P2093
P356
P1476
Comparison of vancomycin, teic ...... difficile-associated diarrhea.
@en
P2093
Graninger W
Hasenhündl M
Hirschl AM
Parschalk B
P304
P356
10.1093/CLINIDS/22.5.813
P407
P577
1996-05-01T00:00:00Z